Welcome to MinttiHealth, your trusted partner in cutting-edge healthcare technology. We are thrilled to introduce our revolutionary AI-powered electronic stethoscope, set to revolutionize the field of respiratory disease diagnosis. With advanced artificial intelligence algorithms seamlessly integrated into a sleek and portable device, our electronic stethoscope empowers healthcare professionals with accurate and efficient diagnostic capabilities like never before.
At MinttiHealth, we understand the critical importance of early detection and precise diagnosis when it comes to respiratory diseases. The human respiratory system is intricate, and identifying subtle abnormalities can be challenging, even for seasoned clinicians. That’s why we have harnessed the power of artificial intelligence and combined it with the time-tested stethoscope to create a game-changing diagnostic tool.
Our AI-powered electronic stethoscope represents a significant leap forward in respiratory disease diagnosis. By leveraging machine learning and deep neural networks, our device can analyze an individual’s lung sounds in real-time, extracting valuable insights that aid in the identification of various respiratory conditions. From common disorders such as asthma and bronchitis to more complex illnesses like pneumonia and chronic obstructive pulmonary disease (COPD), our electronic stethoscope is designed to provide accurate and actionable information for efficient decision-making.
In an era where technology is rapidly transforming healthcare, MinttiHealth remains at the forefront of innovation. Our electronic stethoscope not only enhances diagnostic accuracy but also offers unparalleled convenience. With its user-friendly interface and wireless connectivity, our device seamlessly integrates with our intuitive mobile application, enabling healthcare providers to access patient data and share results effortlessly. Furthermore, its compact design and long battery life ensure that our electronic stethoscope can be utilized in diverse clinical settings, from busy hospitals to remote areas with limited resources.
Nowadays, the respiratory disease has become one of the most dangerous diseases that threaten human health, especially in the developing countries. The early diagnosis of respiratory disease gives patients the opportunity to receive proper treatment in time, and hence artificial intelligent (AI) auscultation using electronic stethoscope may play a promising role.
As we know, the diagnostic accuracy of the stethoscope is limited and highly dependent on clinical expertise. Results are limited by significant heterogeneity. Lung auscultation has a low sensitivity in different clinical settings and patient populations, thereby hampering its clinical utility.
Therefore, Minttihealth has developed three AI systems related to electronic stethoscope based on the heart and lung sound database to improve diagnostic efficiency.
The first one is pediatric adventitious respiratory sound detection (PARSD) system, aiming at detecting pathological adventitious respiratory sounds, including wheeze and crackle, for pediatric auscultation application. The primary care function of PARSD is to judge whether adventitious respiratory sounds exist in recorded lung sound data those are no shorter than 2s.
The second one is aortic stenosis detection & classification (ASDC) system, aiming at detecting aortic stenosis from cardiac auscultation and classifying it into three levels: mild, moderate, and severe. The primary care function of ASDC is to judge whether a subject has got aortic stenosis and what is the level of aortic stenosis, by AI-based cardiac auscultation on auscultatory aortic valve area and second auscultatory aortic valve area.
The last one is congenital heart disease diagnosis (CHDD) system, aiming at giving suggestions on the risk of a pediatric subject having congenital heart disease. The primary care function of CHDD is to give a real-time diagnosis suggestion on the risk of having congenital heart disease, by AI-based auscultation on auscultatory pulmonary valve area and auscultatory mitral valve area.
And now we have built three databases: the pediatric respiratory sound database, the aortic stenosis auscultation database, and the pediatric cardiac sound database for congenital heart disease screening. All of the databases collection has passed the ethics committees, and carried out in the cooperative hospitals. The data can be publicly available for only academic usage.
Mintti Electronic Stethoscope has not only obtained the NMPA, but also is the first and only one with CE mark and FDA clearance in China. It can digitize the heart and lung sound signals, enabling storage and traceability of auscultation signals. Through self-developed heart and lung sound sensor and core signal processing algorithm, a better and clearer auscultation experience can be achieved than traditional stethoscopes.
MinttiHealth is committed to empowering healthcare professionals with state-of-the-art tools that improve patient outcomes. With our AI-powered electronic stethoscope, we strive to make respiratory disease diagnosis more precise, efficient, and accessible. Join us in this transformative journey as we redefine the boundaries of healthcare technology and revolutionize the way respiratory conditions are diagnosed and managed.
To learn more about our AI-powered electronic stethoscope and explore how it can benefit your practice, contact MinttiHealth today. Together, let’s pave the way for a healthier future.
Want to learn more? You can see our Mintti Smartho-D2 Digital Stethoscope on this page. You can also request a Demo from MINTTI for our AI-assisted Digital Stethoscope.